Humana Inc. (NYSE:HUM) Shares Sold by Wealth Dimensions Group Ltd.

Wealth Dimensions Group Ltd. trimmed its stake in Humana Inc. (NYSE:HUM) by 25.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 910 shares of the insurance provider’s stock after selling 304 shares during the quarter. Wealth Dimensions Group Ltd.’s holdings in Humana were worth $288,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Swedbank AB boosted its position in shares of Humana by 3.0% in the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock valued at $33,567,000 after purchasing an additional 3,085 shares during the period. Cerity Partners LLC lifted its stake in Humana by 72.0% during the third quarter. Cerity Partners LLC now owns 31,605 shares of the insurance provider’s stock valued at $10,011,000 after buying an additional 13,233 shares in the last quarter. Meridian Wealth Management LLC acquired a new position in shares of Humana in the third quarter worth about $1,072,000. Charles Schwab Investment Management Inc. boosted its holdings in shares of Humana by 3.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider’s stock worth $284,810,000 after buying an additional 26,056 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Humana by 42.0% in the third quarter. Massachusetts Financial Services Co. MA now owns 391,657 shares of the insurance provider’s stock worth $124,053,000 after acquiring an additional 115,820 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Up 0.8 %

Humana stock opened at $298.11 on Friday. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company’s fifty day moving average price is $276.83 and its two-hundred day moving average price is $330.68. The company has a market capitalization of $35.90 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 2.33 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. On average, analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Wall Street Analyst Weigh In

A number of research firms recently commented on HUM. KeyCorp began coverage on shares of Humana in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Truist Financial reduced their target price on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Deutsche Bank Aktiengesellschaft lowered their price target on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a research note on Tuesday, October 8th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.